| Dr Joshua Maxwell Feuer, MD | |
|
61 Tierra Cielo Ln, Santa Barbara, CA 93105-2357 | |
| (805) 963-0258 | |
| Not Available |
| Full Name | Dr Joshua Maxwell Feuer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 61 Tierra Cielo Ln, Santa Barbara, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215921440 | NPI | - | NPPES |
| 00G503860 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | G50386 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Maxwell Feuer, MD 61 Tierra Cielo Ln, Santa Barbara, CA 93105-2357 Ph: (805) 963-0258 | Dr Joshua Maxwell Feuer, MD 61 Tierra Cielo Ln, Santa Barbara, CA 93105-2357 Ph: (805) 963-0258 |
News Archive
nContact Surgical, Inc., a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias.
Today, the U.S. Food and Drug Administration issued final guidance for developers of mobile medical applications, or apps, which are software programs that run on mobile communication devices and perform the same functions as traditional medical devices. The guidance outlines the FDA's tailored approach to mobile apps.
A new study led by the Translational Genomics Research Institute provides insights into the interplay among bacteria, viruses and the immune system during HIV infection.
Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.
› Verified 3 days ago
Dr. Bonnie Beth Prinz, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 215 Pesetas Ln, Santa Barbara, CA 93110 Phone: 805-681-1760 Fax: 805-681-1768 | |
Hans Richard Barthel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1206 Coast Village Cir, St.f, Santa Barbara, CA 93108 Phone: 805-969-2560 Fax: 805-969-9979 | |
Ashley Thorsell, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 215 Pesetas Ln, Santa Barbara, CA 93110 Phone: 805-681-7820 Fax: 805-681-7869 | |
Anita Rai, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5333 Hollister Ave Ste 255, Santa Barbara, CA 93111 Phone: 805-964-9858 | |
Dr. Josephine Phyllis Preciado, M.D., Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 300 N San Antonio Rd, Santa Barbara, CA 93110 Phone: 805-681-5461 | |
Joseph Aragon, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 317 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-681-1761 Fax: 805-681-1768 | |
Dr. Marcia Barrett Smith, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 715 N Hope Ave, Santa Barbara, CA 93110 Phone: 805-687-3396 |